MTB
42
-4
FIS
50
4
CME
56
-3
BBY
48
2
SHW
53
-2
GME
57
5
DRI
48
-2
CHD
34
-5
IR
58
-2
WY
48
-2
XOM
37
-2
LRCX
65
6
MAT
43
2
FLR
52
4
BXP
49
-3
AMP
54
2
ALL
37
-3
PEP
41
-6
TROW
54
-2
RIG
54
7
MTB
42
-4
FIS
50
4
CME
56
-3
BBY
48
2
SHW
53
-2
GME
57
5
DRI
48
-2
CHD
34
-5
IR
58
-2
WY
48
-2
XOM
37
-2
LRCX
65
6
MAT
43
2
FLR
52
4
BXP
49
-3
AMP
54
2
ALL
37
-3
PEP
41
-6
TROW
54
-2
RIG
54
7
Financhill
Back

RBC Target 2025 Government Bond ETF Vs. Aligos Therapeutics Industry Stock Comparison

Sell
30

RGQN.TO
RBC Target 2025 Government Bond ETF

Last Price:
20.54
Seasonality Move:
0.55%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
34.58
Seasonality Move:
10.65%
Sell
30
RBC Target 2025 Government Bond ETF (RGQN.TO) is a Sell

Is RBC Target 2025 Government Bond ETF a Buy, Sell or Hold?

  • The current RBC Target 2025 Government Bond ETF [RGQN.TO] share price is $20.54. The Score for RGQN.TO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGQN.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RGQN.TO Stock Price Chart

What is RBC Target 2025 Government Bond ETF's stock price today?

  • The RBC Target 2025 Government Bond ETF share price today is $20.54
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGQN.TO is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGQN.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 70.09 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.49 - 20.53) Buy
Bollinger Bands (100): (20.36 - 20.5) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

RGQN.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.53 Buy
20-day SMA: 20.51 Buy
50-day SMA: 20.49 Buy
200-day SMA: 20.28 Buy
8-day EMA: 20.53 Buy
20-day EMA: 20.51 Buy
50-day EMA: 20.48 Buy
200-day EMA: 20.29 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

RBC Target 2025 Government Bond ETF Earnings Growth & RGQN.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

RBC Target 2025 Government Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):